DRACONIS PHARMA | Drug Discovery and Preclinical R&D Solutions
home,page-template-default,page,page-id-16358,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive



Draconis Pharma is a company mainly focused on the reseach of immunological response and the new therapies for the treatment of immune-based diseases such as inflammation, autoimmunity, allergy and related diseases (cancer, pain, etc).


Draconis offers experimental services in the early stages of discovery and preclinical research to pharmaceutical, biotechnological and food companies. Draconis’ scientific expertise guarantees highly customized solutions to evaluate, the efficacy, safety and toxicology of many types of compounds, such as small molecules, proteins, antidodies, RNA-based compounds, vaccines, functional foods or probiotics, in a wide range of target and disease experimental models.


Draconis has developed an own pipeline as a result of its R&D collaborations



Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

Aviso de cookies